NATIONAL CANCER INSTITUTENIH · NATIONAL CANCER INSTITUTENIH

Cancer Molecular Therapeutics

Jackson, Michael (Contact)·SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA·1997–2027·ACTIVE

Donate

INSTITUTION

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, CA

PRINCIPAL INVESTIGATOR

Jackson, Michael (Contact)

FUNDING

$255K

YEAR

1997

MOONBASE SCORE

Still being scored

LOADING MOONBASE SCORE

Abstract

The overall goals of the Cancer Molecular Therapeutics (CMT) Program (formerly Aging, Cancer and Immuno-oncology (ACI)) are to engage active collaborations among members of the program to enable new research initiatives and grant programs that will define how the interplay among cancer cells, immune cells, stromal components, and vasculature regulates the growth and metastasis of solid and hematologic malignancies, and to use this knowledge to discover new, more effective cancer treatments.

NATIONAL CANCER INSTITUTEP30ZCA1-RTRB-Ytherapeuticsgrantengagehematologicdiscoverenabletreatmentsgoalsmolecularsoliddefineoverallcomponentsimmunometastasisactivememberscollaborationsimmune

Are you the primary organization running this research?

The two tools below are built for the principal investigator & host institution behind this project.